Genenta Science CEO to present at U.S. Senate meeting

Genenta Science (GNTA) announced that Pierluigi Paracchi, CEO, will attend as a speaker to the Italy-U.S. meeting “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” scheduled at 2.00 PM on October 25th, 2024 at the U.S. Senate – Washington, D.C. The event is organized by the U.S. National Security Commission on Emerging Biotechnology and the Italian Embassy in the U.S. The upcoming mission to Washington, D.C. is part of the strategic plan of the Italian Working Group on the Internationalization of the Biotech Sector established by the Deputy Prime Minister and Minister of Foreign Affairs Antonio Tajan. Pierluigi Paracchi stated: “With the pandemic, biotechnologies have been elevated to strategic technologies by leading global nations. Italy, with its rich scientific heritage, must ensure that these innovations are rapidly and concretely applied, while preserving them as national assets. At the same time, the internationalization of the sector, collaboration with partner countries, and the attraction of foreign investments are crucial for ensuring competitive growth. Government investment agencies should focus on strategic operations of a competitive scale, aligning with the international standards of countries already leading the sector.”